FUJI SEIKI CO.,LTD.

Business Details

This segment manufactures and sells precision molds for injection molding, as well as systems that combine injection molding machines and other molding peripheral equipment. Manufacturing takes place domestically (Matsuyama Plant) and in China (Fuji Seiki (Changzhou) Co., Ltd.), while subsidiaries in Thailand, China (Shanghai), and Indonesia handle sales. The business operates on a make-to-order basis and aims to secure stable order expansion by providing high-value-added products, with precision molds for medical devices as its core offering. In the first quarter of FY2026 (ending December 2026), amid a challenging order environment, sales decreased compared to the same quarter of the previous year, although the outstanding order backlog (not yet accepted) remained at a high level compared to the previous fiscal year.

Recent Overview

Sales and profit both declined year on year amid a challenging order environment, while the order backlog remained at a high level

In the first quarter of FY2026 (ending December 2026) (January to March 2026), segment sales (including internal transactions) decreased by ¥76 million (8.7%) year on year to ¥801 million. Sales of precision molds for medical devices only increased slightly year on year, but the segment as a whole saw a decrease in sales. Segment profit decreased by ¥13 million (17.3%) year on year to ¥67 million. Meanwhile, the outstanding order backlog (not yet accepted) for this make-to-order business remained at a high level compared to the previous fiscal year, and is expected to contribute to sales recognition going forward.

Key Products

Growth Drivers

• Expanding demand for precision molds for medical devices and increasing orders for high-margin projects
• The outstanding order backlog (not yet accepted) has remained at a high level since the previous fiscal year, which is expected to contribute to sales recognition in subsequent periods
• Securing stable orders through focused sales efforts in medical and food container-related fields in the Japanese market and medical-related fields in the Chinese market
• Strengthening competitiveness by promoting in-house production through intra-group collaboration to reduce costs
• Planned promotion of R&D investment to propose new high-value-added products

Risks

• Since the business operates on a make-to-order basis, performance is heavily influenced by customers' capital investment plans
• Growing uncertainty in overseas economies due to U.S. tariff policy, U.S.-China tensions, and geopolitical risks (including the military conflict between the U.S. and Iran)
• Dependence risk on a specific market due to concentration in the medical device field
• Increasing difficulty in winning orders due to intensifying price and technology competition with competing manufacturers
• Foreign exchange risk (foreign currency exposure associated with business operations in China, Thailand, and Indonesia)